What are norepinephrine reuptake inhibitor drugs?

norepinephrine reuptake inhibitor drugs are pharmacologic agents that share a common mechanism (typically targeting norepinephrine transporter). 2 are currently marketed, with 3 more in clinical development.

What are the marketed norepinephrine reuptake inhibitor drugs?

Marketed norepinephrine reuptake inhibitor drugs include Erdos capsule, Strattera.

norepinephrine reuptake inhibitor

2 marketed 2 in Phase 3 1 in Phase 2

This page covers all norepinephrine reuptake inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting norepinephrine transporter, Sodium-dependent noradrenaline transporter.

Targets

norepinephrine transporter · Sodium-dependent noradrenaline transporter

Marketed (2)

Erdos capsule · Kwang-Ha Yoo · Psychiatry
Erdos capsule works by inhibiting the reuptake of norepinephrine, a neurotransmitter that plays a key role in attention and arousal.
Strattera · Eli Lilly · Neuroscience
Strattera works by blocking the reabsorption of norepinephrine in the brain, allowing more of this neurotransmitter to be available for use.

Phase 3 pipeline (2)

SSR591813L (dianicline) · Sanofi · Central Nervous System
SSR591813L (dianicline) is a norepinephrine reuptake inhibitor.
H077 sustained-release tablet · Shanghai Huilun Pharmaceutical Co., Ltd. · Depression
H077 sustained-release tablet is a medication that works by inhibiting the reuptake of a specific neurotransmitter.

Phase 2 pipeline (1)

Ammoxetine Hydrochloride Enteric-coated Tablets · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Psychiatry
Ammoxetine hydrochloride is a norepinephrine reuptake inhibitor.